Antiarrhythmic gene therapy: will biologics replace catheters, drugs and devices?

The clinical management of heart rhythm disorders still constitutes a major challenge. The development of alternatives to current approaches is of significant interest in order to establish more effective therapies that increase quality of life and reduce symptoms and hospitalizations. Over the past...

Full description

Saved in:
Bibliographic Details
Main Authors: Lugenbiel, Patrick (Author) , Schweizer, Patrick Alexander (Author) , Katus, Hugo (Author) , Thomas, Dierk (Author)
Format: Article (Journal)
Language:English
Published: 2 September 2016
In: European journal of pharmacology
Year: 2016, Volume: 791, Pages: 264-273
ISSN:1879-0712
DOI:10.1016/j.ejphar.2016.09.001
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.ejphar.2016.09.001
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S001429991630560X
Get full text
Author Notes:Patrick Lugenbiel, Patrick A. Schweizer, Hugo A. Katus, Dierk Thomas
Description
Summary:The clinical management of heart rhythm disorders still constitutes a major challenge. The development of alternatives to current approaches is of significant interest in order to establish more effective therapies that increase quality of life and reduce symptoms and hospitalizations. Over the past two decades the mechanistic understanding of pathophysiological pathways underlying cardiac arrhythmias has advanced profoundly, opening up novel avenues for mechanism-based therapeutic approaches. In particular, gene therapy offers greater selectivity than small molecule-based or interventional treatment. The gene of interest is packaged into viral or non-viral carriers and delivered to the target area via direct injection or using catheter-based techniques, providing the advantage of site-restricted action in contrast to systemic application of drugs. This work summarizes the current knowledge on mechanistic background, application strategies, and preclinical outcome of antiarrhythmic gene therapy for atrial fibrillation, ventricular tachycardia, and modulation of sinus node function.
Item Description:Gesehen am 03.06.2019
Physical Description:Online Resource
ISSN:1879-0712
DOI:10.1016/j.ejphar.2016.09.001